Q: Hi on july 18th you suggested to Gary IHI And XHE for medical device etf please explain and compare the two ,if you only have funds for one which would you chose thanks
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Favorite pick between these two in the health/tech space and why?
Q: Hi,
What are your thoughts on Merck as an investment, the company’s potential growth and risk? My interest started in Merck because of their immunotherapy drug... Keytruda. Keytruda has eliminated some of my mom’s melanoma tumors and shrinking cancer in two other areas of her body. Other melanoma patients are seeing positive results. Melanoma cannot be treated with chemo. This drug is now being tried on some liver cancers and was initially developed for some types of lung cancer. I really don’t know a lot about this company and would like your opinion.
Thanks,
Kerri
What are your thoughts on Merck as an investment, the company’s potential growth and risk? My interest started in Merck because of their immunotherapy drug... Keytruda. Keytruda has eliminated some of my mom’s melanoma tumors and shrinking cancer in two other areas of her body. Other melanoma patients are seeing positive results. Melanoma cannot be treated with chemo. This drug is now being tried on some liver cancers and was initially developed for some types of lung cancer. I really don’t know a lot about this company and would like your opinion.
Thanks,
Kerri
Q: I think that self directed medical care is the inevitable future of medicine for a number of reasons. Would you be inclined to bless RHT?
Q: Hello team,
Any reason for continued decline in SP other than the recent financing? How do you feel about the company at this point? Would you add to an existing position?
Thanks as always!
Any reason for continued decline in SP other than the recent financing? How do you feel about the company at this point? Would you add to an existing position?
Thanks as always!
Q: Hi guys:
I’m down 36 percent on Crh . Should I sell this name and take the remaining money to buy Covalon. Would this be a wise move or a ridiculous move?
Thanks
Mark
I’m down 36 percent on Crh . Should I sell this name and take the remaining money to buy Covalon. Would this be a wise move or a ridiculous move?
Thanks
Mark
Q: Your thoughts on Endo currently pls for a buy and long term hold
Q: Hi Ryan & Peter,
Would like your opinion about MNK.
Thanks,
Would like your opinion about MNK.
Thanks,
Q: Do you now of an ETF which covers medical supplies/equipment/ devices and not drugs? Thanks
Q: I read in a reply to a question about Intelgenx technologies you indicated that insiders owned less than 2%, insiders own close to 18%. Company seems to have a lot of irons in the fire namely exclusivity with Eli Lily for their Cialis drug partnership with Endo/Par for subaxone, 4drug app to be filed by 2018 in collaboration with Insud pharma, approval for migraine drug in Europe,health canada approval for manufacturing site, Alzheimer's trial Maxim group initiating with a 12month us$3 target. I am heavily invested in the company and would love to hear unbiased thoughts on the company in light of the recent developments. Thanks and look forward to ur reply
Q: Johnson and Johnson is a highly rated company. However they are facing a large number of law suits, mostly related to talcum powder. Although the scientific basis for these lawsuits is extremely weak, I am concerned about the legal system in the USA. Would you recommend I keep holding my JNJ shares or sell and invest in something else in the USA? Diversification is not an issue.
Q: Regarding your comment on GUD this morning, I think Canaccord raised their price estimate from $7.90 to $10.75 which could account for the price bump.
Q: GUD is up almost 10% in the past week or so. I see no news, I think its a head fake.
I've been out of the stock since $9.5 and have a limit order to buy at $7.50. What do you think?
Sheldon
I've been out of the stock since $9.5 and have a limit order to buy at $7.50. What do you think?
Sheldon
Q: What do you think about Wellcare? I'm looking for stability, security and some growth.
Q: Hi Ryan.I am up $18000. on 3100 shares of SIS..With the way it looks should I sell 1-2 of these shares or should i just hang in there. If I should sell some where would you put the$$. Thanks in advance.. Cliff
Q: Hi 5I
Any comments on the recent downturn on TH. Earnings seemed OK.
Thanks Bob
Any comments on the recent downturn on TH. Earnings seemed OK.
Thanks Bob
Q: Prometic is up 12% today on high volume. It has been such a sleepy hollow stock that it is a bit of a hock to see it moving. Are you aware of any news on this company?
Thanks, Peter
Thanks, Peter
Q: I recently entered into a 2% position in the recent dip when Amazon announced the PillPack acquisition. This dip was shortly after WBA's addition to the DOW. Do companies historically see short to medium term strength after being added to the DOW? The long term trend isn't great on WBA so I am trying to decide whether I should lock in profits and enjoy the successful trade or hold it longer term as an investment. My healthcare allocation is ~5% including WBA.
Q: Hello Peter / Ryan and Team,
Looking at COV. Seems like there is a huge difference between Shares Outstanding and Floating shares. Does this mean that there are a lot of shares locked by insiders? When are these scheduled to be able to be traded and is that a concern for the future with the stock up so much? With the large run up lately, do you still feel it is a good buying opportunity or would you wait for a pull back as the chart gives me a bit of a pause.
Thanks for all you do,
Wes
Looking at COV. Seems like there is a huge difference between Shares Outstanding and Floating shares. Does this mean that there are a lot of shares locked by insiders? When are these scheduled to be able to be traded and is that a concern for the future with the stock up so much? With the large run up lately, do you still feel it is a good buying opportunity or would you wait for a pull back as the chart gives me a bit of a pause.
Thanks for all you do,
Wes
Q: Mr. Hodson, what is this matter about GUD being reassessed for past activities dating back to 2014. Is this a serious matter ? What is the likely outcome in your opinion ?